Article Text

Download PDFPDF
Improving hepatitis C services across the UK: response to a walk-in HCV testing service
  1. R F C D’Souza1,
  2. M J Glynn1,
  3. E Alstead1,
  4. G R Foster1,
  5. I Ushiro-Lumb2
  1. 1Hepatobiliary Group, Barts and The London, Queen Mary’s School of Medicine and Dentistry, London, UK
  2. 2Department of Virology, Barts and The London, Queen Mary’s School of Medicine and Dentistry, London, UK
  1. Correspondence to:
    Professor G R Foster
    Hepatobiliary Group, Department of Gastroenterology, DDRC, Turner St, London E1 2AD, UK; g.r.fosterqmul.ac.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The Department of Health (DH) estimates that approximately 0.4% of the UK population are chronically infected with hepatitis C virus (HCV) (that is, 200 000 people). As few as 10% of these individuals, who are at risk of end stage liver disease, are thought to be aware of their infection. Clearly action is required to identify and treat these patients with current drugs (pegylated interferons …

View Full Text

Footnotes

  • Conflict of interest: Dr Foster acts as a consultant to companies who sell drugs for the treatment of viral hepatitis and has received research funding from such companies. He has received fees from companies who market antiviral therapeutics.